UK government to extend controversial Palantir NHS contract as it draws up plan for British alternative – as it happened

Palantir’s NHS contract is for running a government AI system that brings scattered medical files together. The aim is to make important information easier to use across healthcare services. That matters because fragmented records can slow decisions and complicate patient care.

The system could help hospitals coordinate discharges more quickly and schedule surgeries more efficiently. It is also intended to deliver other potentially life-saving improvements. Palantir’s platform is the technology currently used to connect and work with the NHS data systems involved.

The contract remains politically controversial. MPs and campaigners have called for it to be cancelled, while NHS staff and many trusts dispute the evidence of patient benefit. Ministers plan to extend the arrangement for now, then begin a procurement process for a British alternative that could replace Palantir in two years.

Palantir’s NHS health contract is worth £330m. The size of the deal helps explain why its future has attracted intense political attention. It involves a central system intended to connect medical information and support NHS operations.

Ministers are expected to extend the arrangement before launching a procurement process for a UK technology alternative. The reported plan is for Palantir to potentially be replaced in two years. This means the company may continue operating the system during the transition rather than leave immediately.

The plan has not yet been finally approved, although it is expected to be signed off soon. The extension follows a review that judged activating the contract’s break clause too disruptive. Meanwhile, critics continue to question the company’s role, and many NHS trusts have rejected using its platform.

Ministers are extending Palantir’s contract because removing the company immediately could disrupt NHS data systems. A review reportedly concluded that using the contract’s break clause would be too disruptive. The government is therefore choosing continuity while it considers a longer-term change.

The system connects scattered medical files and supports functions such as hospital discharges and surgery scheduling. Ending the contract abruptly could interfere with those arrangements before another provider is ready. An extension creates time to design and run a procurement process for a British alternative.

The decision does not settle the political argument. Yvette Cooper has faced pressure from MPs and campaigners to axe the contract. Palantir says ending it would put politics above patients, while NHS staff and many trusts contest the evidence of patient benefit. The plan is expected to be signed off soon.

The clearest possible consequence is disruption to NHS data systems. Palantir’s platform currently supports a system designed to connect scattered medical files and improve hospital operations. Removing it suddenly could unsettle those arrangements before a replacement exists.

The article gives practical examples of the services at stake. The system aims to speed hospital discharges and improve surgery scheduling, alongside other potentially life-saving improvements. If the platform were removed abruptly, those planned benefits could be delayed or interrupted. The article does not specify individual hospitals or exact service failures.

That risk is why ministers favour an extension rather than immediately using the contract’s break clause. They want time to arrange a British alternative through procurement. However, the continuation remains contested: many NHS trusts have rejected Palantir’s platform, and NHS staff dispute evidence that it benefits patients.

The government and its ministers are central to the decision, with health secretary Yvette Cooper facing calls to cancel Palantir’s contract. MPs and campaigners are also pressing for change. A review has informed the reported decision to extend the contract.

Palantir is directly involved as the current supplier. Its UK and Europe chief executive, Louis Mosley, defended the contract and criticised opponents. NHS staff and many NHS trusts are important voices too, because they have challenged the evidence of patient benefit or rejected the platform’s use.

The future decision will also involve the government’s procurement process for a British alternative. The article does not name the department or organisations that would run the competition. Green party leader Zack Polanski has condemned the reported extension, showing that political parties are part of the wider debate. The plan is expected to receive formal sign-off soon.

The proposed British alternative would be chosen through a government procurement process. That means ministers would invite technology providers to compete for the work, rather than selecting a replacement informally. The article does not provide the timetable, scoring criteria or list of eligible suppliers.

Palantir would potentially keep running the system during the transition. Ministers first plan to extend its contract, then seek a UK technology alternative. The new provider would need to take over the role currently performed by Palantir’s platform, which connects scattered medical files and supports NHS operations.

The reported target is replacement in two years. The plan is expected to be signed off soon, but it is not described as final in the article. The procurement’s outcome could determine whether Palantir leaves the NHS system, while an abrupt break is being avoided because a review found it would be too disruptive.

Linking medical records can give healthcare workers a more joined-up view of information held in separate places. AI could then help identify patterns, organise data and support administrative decisions. In this case, the intended benefits include faster hospital discharges and better surgery scheduling.

The potential gains depend on accurate records, reliable systems and appropriate use of patient data. A private technology company handling such information creates risks around privacy, security, access and accountability. Concentrating sensitive data in one platform could also make failures or misuse more consequential. The article does not describe specific breaches or safeguards.

The political dispute reflects these competing concerns. Palantir says removing it would put politics above patients, while critics question its contracts with the Israeli military and Donald Trump’s homeland security crackdown. NHS staff and many trusts contest the evidence of patient benefit. Ministers are seeking a British alternative, but will extend the current contract first.